FIRM FIXED PRICENO SET ASIDE USED.

ORGANON LLC - NEW AWARD FOR RENFLEXIS (INFLIXIMAB-ABDA) 100MG VIAL WITH ORGANON LLC. ORDERING PERIOD IS SEPTEMBER 1, 2023 TO AUGUST 31, 2024 WITH FOUR ONE-YEAR OPTIONS.

PIID: 36E79723D0022Solicitation ID: 36E79723R0013

Signed Date: Dec 2, 2025Effective Date: Sep 1, 2023

Vendor

ORGANON LLC

NAICS

325412

Signed Date

Dec 2, 2025

Key Details

Dollars Obligated

Base & All Options

Awarding Agency

Department of Veterans Affairs

Awarding Sub-Agency

Department of Veterans Affairs

NAICS Code

325412 - PHARMACEUTICAL PREPARATION MANUFACTURING

Product Service Code

6505 - DRUGS AND BIOLOGICALS

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Description

NEW AWARD FOR RENFLEXIS (INFLIXIMAB-ABDA) 100MG VIAL WITH ORGANON LLC. ORDERING PERIOD IS SEPTEMBER 1, 2023 TO AUGUST 31, 2024 WITH FOUR ONE-YEAR OPTIONS.

Context & Analysis

On Dec 2, 2025, Department of Veterans Affairs to ORGANON LLC for new award for renflexis (infliximab-abda) 100mg vial with organon llc. ordering period is september 1, 2023 to august 31, 2024 with four one-year options.. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 5 offers received. The procurement used a NO SET ASIDE USED. set-aside.